ARISTOS 2 VETERINARY

국가: 이스라엘

언어: 영어

출처: Ministry of Health

유효 성분:

MARBOFLOXACIN

제공처:

ROMAT LTD

약제 형태:

SOLUTION FOR INJECTION

구성:

MARBOFLOXACIN 20 MG / 1 ML

관리 경로:

S.C, I.M, I.V

처방전 유형:

Required

Manufactured by:

FATRO S.P.A., ITALY

치료 징후:

In pre-ruminant and ruminant calves: Treatment of respiratory infections caused by susceptible strains of Pasteurella multocida, Mannheimia (Pasteurella) haemolytica and Mycoplasma bovis.In pigs: Treatment of respiratory infections caused by susceptible strains of Actinobacillus pleuropneumoniae, Mycoplasma hyopneumoniae and Pasteurella multocida. The product should only be used when strain susceptibility has been tested.

승인 날짜:

2020-07-19

환자 정보 전단

CONSUMER LEAFLET FOR A VETERINARY PRODUCT
This medicine is marketed according to a veterinarian’s prescription
only.
For animal use only
1.
NAME, FORM AND STRENGTH OF THE VETERINARY MEDICINE
ARISTOS 2 VETERINARY, SOLUTION FOR INJECTION
2.
ACTIVE INGREDIENT and its quantity in a dose unit
One ml solution contains:
Marbofloxacin 20 mg
Inactive
excipients:
Disodium
edetate
0.1
mg/ml,
Thioglycerol
0.5
mg/ml,
Metacresol 2 mg/ml. For a full list of excipients see section 13
below.
3.
WHAT IS THE MEDICINE INTENDED FOR
IN PRE-RUMINANT AND RUMINANT CALVES:
- Treatment of respiratory infections caused by susceptible strains of
_Pasteurella _
_multocida, Mannheimia (Pasteurella) haemolytica_ _and Mycoplasma
bovis._
IN PIGS:
- Treatment of respiratory infections caused by susceptible strains of
_Actinobacillus _
_pleuropneumoniae, Mycoplasma hyopneumoniae_ and _Pasteurella
multocida._
The product should only be used when strain susceptibility has been
tested.
Therapeutic group: fluoroquinolone antibiotics for systemic use
.
4.
CONTRAINDICATIONS
Do not administer in the event of bacteria resistant to other
fluoroquinolones (cross-
resistance).
Do not administer to an animal with known hypersensitivity to
marbofloxacin or to
another quinolone.
5.
SIDE EFFECTS
Administration by subcutaneous and intramuscular route may cause
temporary
swelling.
Administration by intramuscular route may cause pain and inflammatory
lesions at
the injection site. Inflammatory lesions can last for 6 days in pigs
and 12 days in
calves.
Side effects can be reported to the Ministry of Health by clicking on
the link "Adverse
Drug Reactions Report" that appears on the home page of the Ministry
of Health web
site (www.health.gov.il), which leads to an online form for reporting
side effects.
Alternatively you can use the following link:
https://sideeffects.health.gov.il
_ _
_ _
6.
TARGET SPECIES
Bovines and porcines during fatting.
7.
DOSAGE AND ADMINISTRATION
In preruminant and ruminant calves:
2 mg marbofloxacin per kg live weight, i.e. 1 ml of solutio